Pharma News

The appearance of infectious diseases in new places and new hosts, such as West Nile virus and Ebola, is a predictable result of climate change, scientists say. Humans can expect more such illnesses to emerge in the future, as climate change shifts habitats and brings wildlife, crops, livestock, and humans into contact with pathogens to which they are susceptible but to which they have never been exposed before, researchers said.

An experimental drug may help treat patients with hormone-resistant breast cancer, scientists say. Palbociclib, an investigational oral medication that works by blocking molecules responsible for cancer cell growth, is well tolerated and extends progression-free survival (PFS) in newly diagnosed, advanced breast cancer patients, including those whose disease has stopped responding to traditional endocrine treatments, researchers said.

Our taste cells regenerate about every 10 days, much like skin cells, scientists say.A person who loses their hearing may never get it back. It is also likely that they won't get back any brain cells they may have burned out.

Mylan N.V. and Mylan Inc. announced the U.S. launch of Buprenorphine Hydrochloride Sublingual Tablets (2 mg and 8 mg) and Disulfiram Tablets USP (250 mg and 500 mg) which are the generic versions of Reckitt Benckiser's Subutex® Sublingual Tablets and Odyssey Pharmaceutical's Antabuse^® respectively.

[adsense:336x280:8701650588]

In a remarkable medical feat, neurologist Dr. Naeem Sadiq has successfully treated a patient suffering from Parkinson's disease (PD) for the last 12 years by using stem cell therapy. 59 years old Ashok Kumar, who couldn't talk, walk, sit or eat due to the tremors and rigidity is now doing all these activities without any support, much to the astonishment of his family. Just two doses of stem cell transplant in a span of four months helped Kumar to recover.

Japanese researchers have found that a substance in black tea may be effective for treating osteoporosis, a disease that causes bones to become weak and brittle.

Researchers, led by an Indian-origin scientist, have developed a new blood test that may detect a broad range of cancers in the earliest stages by forcing tumours to create a unique protein. Stanford University Medical School researchers injected DNA microcircles, a customised genetic construct consisting of tiny rings of DNA, into mice.